Efficacy of Liraglutide in Obesity in Children and Adolescents: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
青少年肥胖症中 Liraglutide 的療效:隨機對照試驗的系統性回顧和荟萃分析。
Children (Basel) 2023-03-15
Usage of Glucagon-Like Peptide-1 for Obesity in Children; Updated Review of Clinicaltrials.gov.
兒童肥胖症中葡萄糖樣肽-1的使用;Clinicaltrials.gov 最新評論。
J Multidiscip Healthc 2023-08-08
Efficacy and safety of liraglutide for weight management in children and adolescents: a systematic review and meta-analysis of randomized controlled trials.
青少年肥胖管理的利拉魯肽療效和安全性:隨機對照試驗的系統性回顧和荟萃分析。
Eur J Pediatr 2024-04-04
Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26-week open-label feasibility study.
Liraglutide 3.0 毫克每日治療在精神病學法醫科室住院患者的超重和肥胖:一項為期 26 週的開放標籤可行性研究。
Acta Psychiatr Scand 2024-04-17
Single-Center Experience of Using Liraglutide in Adolescents With Obesity +/- Type 2 Diabetes.
單一中心使用 Liraglutide 治療青少年肥胖症 +/- 2 型糖尿病的經驗。
Cureus 2024-05-23
[Changes in weight, body composition, metabolic parameters and vitamin D in subjects with grade 3 and 4 obesity treated with liraglutide 3 mg].
[接受 liraglutide 3 mg 治療的 3 級和 4 級肥胖患者體重、身體組成、代謝參數及維生素 D 的變化]
Nutr Hosp 2024-07-22
An open-label 16-week study of liraglutide in adolescents with obesity post-sleeve gastrectomy.
一項針對接受袖狀胃切除術後青少年肥胖的 liraglutide 開放標籤 16 週研究。
Pediatr Obes 2024-08-05